Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis
Multiple sclerosis: Understanding the role of melatonin Regulating melatonin levels holds promise as a therapy for multiple sclerosis (MS), but treatment must be tailored to each individual. In MS, the immune system destroys the myelin sheath surrounding nerves, disturbing brain–body communication....
Main Authors: | Majid Ghareghani, Vincent Pons, Nataly Laflamme, Kazem Zibara, Serge Rivest |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-01-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-023-00925-1 |
Similar Items
-
Author Correction: Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis
by: Majid Ghareghani, et al.
Published: (2023-02-01) -
PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple Sclerosis
by: Majid Ghareghani, et al.
Published: (2022-03-01) -
Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway
by: Majid Ghareghani, et al.
Published: (2018-10-01) -
Patrolling Monocytes Watch Over Relapse
by: Melania Tesio
Published: (2020-08-01) -
Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis
by: Majid Ghareghani, et al.
Published: (2019-02-01)